A transcriptome analysis of basal and stimulated VWF release from endothelial cells derived from patients with type 1 VWD

Key Points • Transcriptome-wide differences exist between type 1 VWD and control-derived endothelial cells during basal and stimulated VWF release.• Dysregulation of specific miRNA-mRNA axes may contribute to the pathogenesis of type 1 VWD.

[1]  A. Iorio,et al.  von Willebrand factor propeptide variants lead to impaired storage and ER retention in patient‐derived endothelial colony‐forming cells , 2022, Journal of thrombosis and haemostasis : JTH.

[2]  J. Di Paola,et al.  Single Cell Transcriptional Analysis of Human Endothelial Colony Forming Cells from Patients with Low VWF Levels. , 2022, Blood.

[3]  Yuqin Fan,et al.  Hypomethylation and downregulation of miR-23b-3p are associated with upregulated PLAU: a diagnostic and prognostic biomarker in head and neck squamous cell carcinoma , 2021, Cancer cell international.

[4]  R. Mustafa,et al.  ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease. , 2021, Blood advances.

[5]  R. Mustafa,et al.  ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease. , 2021, Blood advances.

[6]  E. Weijers,et al.  Endothelial characteristics in healthy endothelial colony forming cells; generating a robust and valid ex vivo model for vascular disease , 2020, Journal of thrombosis and haemostasis : JTH.

[7]  Z. Sauna,et al.  Role of microRNAs in Hemophilia and Thrombosis in Humans , 2020, International journal of molecular sciences.

[8]  J. Eikenboom,et al.  von Willebrand factor and factor VIII levels after desmopressin are associated with bleeding phenotype in type 1 VWD. , 2019, Blood advances.

[9]  T. Tuschl,et al.  Evaluating gastroenteropancreatic neuroendocrine tumors through microRNA sequencing. , 2019, Endocrine-related cancer.

[10]  A. Koster,et al.  Weibel-Palade Body Localized Syntaxin-3 Modulates Von Willebrand Factor Secretion From Endothelial Cells , 2018, Arteriosclerosis, thrombosis, and vascular biology.

[11]  S. Archer,et al.  Abnormal angiogenesis in blood outgrowth endothelial cells derived from von Willebrand disease patients , 2017, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[12]  C. Graham,et al.  Comprehensive immune transcriptomic analysis in bladder cancer reveals subtype specific immune gene expression patterns of prognostic relevance , 2017, Oncotarget.

[13]  D. Cutler,et al.  von Willebrand factor multimerization and the polarity of secretory pathways in endothelial cells. , 2016, Blood.

[14]  Måns Magnusson,et al.  MultiQC: summarize analysis results for multiple tools and samples in a single report , 2016, Bioinform..

[15]  D. Bellissimo,et al.  Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States. , 2016, Blood.

[16]  R. Bierings,et al.  Interaction between MyRIP and the actin cytoskeleton regulates Weibel–Palade body trafficking and exocytosis , 2016, Journal of Cell Science.

[17]  Roland Eils,et al.  circlize implements and enhances circular visualization in R , 2014, Bioinform..

[18]  Paul Theodor Pyl,et al.  HTSeq – A Python framework to work with high-throughput sequencing data , 2014, bioRxiv.

[19]  M. Periyasamy,et al.  miR-23b regulates cytoskeletal remodeling, motility and metastasis by directly targeting multiple transcripts , 2013, Nucleic acids research.

[20]  P. Reitsma,et al.  Analysis of the storage and secretion of von Willebrand factor in blood outgrowth endothelial cells derived from patients with von Willebrand disease. , 2013, Blood.

[21]  R. Dahiya,et al.  miR-23b represses proto-oncogene Src kinase and functions as methylation-silenced tumor suppressor with diagnostic and prognostic significance in prostate cancer. , 2012, Cancer research.

[22]  Thomas Tuschl,et al.  Barcoded cDNA library preparation for small RNA profiling by next-generation sequencing. , 2012, Methods.

[23]  Guangchuang Yu,et al.  clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.

[24]  Davis J. McCarthy,et al.  Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation , 2012, Nucleic acids research.

[25]  Changhong Sun,et al.  Genome-wide functional screening of miR-23b as a pleiotropic modulator suppressing cancer metastasis. , 2011, Nature communications.

[26]  P. James,et al.  A prospective evaluation of the prevalence of symptomatic von Willebrand disease (VWD) in a pediatric primary care population , 2010, Pediatric blood & cancer.

[27]  P. James,et al.  The prevalence of symptomatic von Willebrand disease in primary care practice , 2010, Journal of thrombosis and haemostasis : JTH.

[28]  C. Sander,et al.  A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing , 2007, Cell.

[29]  P. Collins,et al.  An investigation of the von Willebrand factor genotype in UK patients diagnosed to have type 1 von Willebrand disease , 2006, Thrombosis and Haemostasis.

[30]  P. Mannucci,et al.  Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor , 2006, Journal of thrombosis and haemostasis : JTH.

[31]  M. Rondaij,et al.  Dynein-dynactin complex mediates protein kinase A-dependent clustering of Weibel-Palade bodies in endothelial cells. , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[32]  T. Podor,et al.  Platelets from patients with the Quebec platelet disorder contain and secrete abnormal amounts of urokinase-type plasminogen activator. , 2001, Blood.

[33]  C. Wollheim,et al.  Regulated von Willebrand factor secretion is associated with agonist-specific patterns of cytoskeletal remodeling in cultured endothelial cells. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[34]  L. Tsai,et al.  ABO genotyping by mutagenically separated polymerase chain reaction. , 1996, Forensic science international.

[35]  I. Macgregor,et al.  Study of endothelial t-PA and vWf in normal subjects and in von Willebrand's disease. , 1994, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[36]  E. Weibel,et al.  NEW CYTOPLASMIC COMPONENTS IN ARTERIAL ENDOTHELIA , 1964, The Journal of cell biology.

[37]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[38]  L. O'Brien,et al.  The mutational spectrum of type 1 von Willebrand disease: Results from a Canadian cohort study. , 2007, Blood.

[39]  J. Goudemand,et al.  Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD). , 2007, Blood.

[40]  C. Wollheim,et al.  Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP. , 2000, The Journal of clinical investigation.

[41]  F. Cohen,et al.  Biochemistry and genetics of von Willebrand factor. , 1998, Annual review of biochemistry.

[42]  B. Binder,et al.  Secretory response of the vessel wall to DDAVP and venous occlusion in von Willebrand's disease. , 1994, Acta haematologica Polonica.

[43]  A. Venot,et al.  Impaired fibrinolytic response to DDAVP in patients with von Willebrand's disease. , 1992, Nouvelle revue francaise d'hematologie.